Operates as a third-party administrator (TPA) for health insurance, processing claims, managing hospital networks, and providing technology platforms on behalf of insurers, corporate employers, government schemes, and individual policyholders. Group insurance administration is the largest line, contributing 69.5% of operating income (₹629.1 crore) and administering over ₹23,000 crore of group premiums at a 33.7% market share. Government health schemes contribute 12.6% (₹113.6 crore), retail (individual) insurance 10.6% (₹95.5 crore), and international operations 4.5% (₹41.1 crore) through the UK subsidiary Mayfair We Care and a Thailand strategic partnership. A technology and SaaS business, contributing 2.5% of operating income (₹21.7 crore), sells the MAtrix claims platform, MAven Guard fraud detection, and Raksha Prime pre-bill discharge tools to insurers and other TPAs. The MAtrix platform processes roughly one million claims per month across 6,000 networked hospitals, and MAven Guard prevented ₹540 crore of fraud in FY26. Employee costs are the dominant cost line at 43.6% of revenue, with other operating expenses at 37.1% and depreciation at 8.5%. The business is asset-light: total capex runs at 6.2% of revenue and the company became debt-free in January 2026 with ₹260.5 crore of free cash flow. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Group health insurance administration (70%), Government health schemes (13%), Retail/individual health insurance (11%), International operations (5%), Technology and SaaS (3%). Asset-light services business administering health insurance claims and selling technology to insurers, with employee costs dominating the cost stack.
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 635 | 723 | 905 |
| EBITDA (ex other income) | 112 | 154 | 160 |
| margin % | 17.7 | 21.3 | 17.7 |
| Owners' profit | 67 | 91 | 88 |
| EPS, as reported (₹) | 9.71 | 12.91 | 12.14 |
| ROE % · ROCE % | 14.4 · 16.5 | 16.6 · 18.7 | 10.5 · 10.9 |
| Debt / equity (x) | 0.00 | 0.27 | 0.00 |
| Cash from operations | 66 | 138 | 118 |
| Capex | (18) | (46) | (56) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 181 | 186 | 189 | 191 | 233 | 240 | 242 | 237 |
| Profit before tax | 29 | 27 | 30 | 31 | 13 | 8 | 28 | 35 |
| Net profit | 21 | 30 | 22 | 23 | 8 | 4 | 54 | 28 |
| EPS (₹) | 2.99 | 4.20 | 3.05 | 3.18 | 1.13 | 0.51 | 7.33 | 3.71 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 25.1 | 243.3 | 1 of 2 | 100% |
| P/B | 2.8 | 5.4 | 1 of 2 | 100% |
| ROCE | 8.6 | 4.6 | 1 of 2 | 100% |
| ROE | 10.5 | 6.1 | 1 of 2 | 100% |
| Debt / Equity | 0.0 | 0.0 | 1 of 2 | 0% |
| EBITDA margin | 24.7 | 12.9 | 1 of 2 | 100% |
| Revenue growth | 24.1 | 20.4 | 1 of 2 | 100% |
| Profit growth | 21.9 | 21.9 | 7 of 12 | 46% |
| Market cap | 2380 | 26676 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 8 Sept 2026 · SBI General Insurance trims Medi Assist stake in open market sale | ownership changes | high | — | — |
| 2 Sept 2026 · Newspaper notice for 26th AGM and e-voting information published | compliance | minimal | — | — |
| 1 Sept 2026 · AGM notice and FY26 annual report; chairman role change and dividend proposed | board shareholder meetings | medium | — | — |
| 1 Sept 2026 · Medi Assist shares AGM, dividend details for FY26; notice for non-registered email holders | compliance | minimal | — | — |
| 1 Sept 2026 · Medi Assist 26th AGM on Sep 24: Rs 2 dividend, Chairman role change | board shareholder meetings | low | — | — |
| 14 Aug 2026 · Medi Assist Q1 FY27 Earnings Call: Revenue up 25%, Margins Expand | investor communications | medium | — | — |
| 12 Aug 2026 · Newspaper ad for 26th AGM and FY26 final dividend record date | compliance | minimal | — | — |
| 11 Aug 2026 · AGM Sep 24; final dividend Rs.2 per share; record date Sep 11, 2026 | compliance | minimal | — | — |
| 10 Aug 2026 · Audio link shared for Q1 FY27 Earnings Call | investor communications | low | — | — |
| 9 Aug 2026 · Q1 FY27: Revenue up 24.1%, EBITDA margin contracts 175 bps | results | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) |
| 2 of 2 |
| 0% |
| A state: the latest filed quarter and the measured reactions |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.